AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Mohty, M Faucher, C Chabannon, C Vey, N Stoppa, AM Ladaique, P Novakovitch, G Olivero, S Bouabdallah, R Gastaut, JA Maraninchi, D Blaise, D
Citation: M. Mohty et al., CD34(+) immunoselected cells for poor graft function following allogeneic BMT, CYTOTHERAPY, 2(5), 2000, pp. 367-370

Authors: Giraud, P Thuret, I Reviron, D Chambost, H Brunet, C Novakovitch, G Farnarier, C Michel, G
Citation: P. Giraud et al., Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience, BONE MAR TR, 25(1), 2000, pp. 53-57

Authors: Genre, D Viens, P Gravis, G Bertucci, F Cowen, D Novakovitch, G Dermeche, S Chabannon, C Oziel-Taieb, S Camerlo, J Houvenaeghel, G Jacquemier, J Maraninchi, D
Citation: D. Genre et al., Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: A phase I-II study, ANTICANC R, 20(3B), 2000, pp. 2033-2040

Authors: Olivero, S Novakovitch, G Ladaique, P Sainty, D Viret, F Faucher, C Stoppa, AM Blaise, D Chabannon, C
Citation: S. Olivero et al., T-cell depletion of allogeneic bone marrow grafts: enrichment of mononuclear cells using the COBE Spectra cell processor, followed by immunoselectionof CD34(+) cells, CYTOTHERAPY, 1(6), 1999, pp. 469-477

Authors: Chabannon, C Novakovitch, G Blache, JL Olivero, S Camerlo, J Genre, D Maraninchi, D Viens, P
Citation: C. Chabannon et al., The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell (R) technology, HEM CELL TH, 41(2), 1999, pp. 78-81

Authors: Viret, F Blaise, D Bouabdallah, R Stoppa, AM Novakovitch, G Faucher, C Vey, N Camerlo, J Oziel-Taieb, S Ladaique, P Gastaut, JA Maraninchi, D Chabannon, C
Citation: F. Viret et al., Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement, HEM CELL TH, 41(1), 1999, pp. 5-11

Authors: Munzenberger, N Fortanier, C Macquart-Moulin, G Faucher, C Novakovitch, G Maraninchi, D Moatti, JP Blaise, D
Citation: N. Munzenberger et al., Psychosocial aspects of haematopoietic stem cell donation for allogeneic transplantation: How family donors cope with this experience, PSYCHO-ONC, 8(1), 1999, pp. 55-63

Authors: Chabannon, C Blache, JL Sielleur, I Douville, J Faucher, C Gravis, G Arnoulet, C Oziel-Taieb, S Blaise, D Novakovitch, G Camerlo, J Chabbert, I Genre, D Appel, M Armstrong, D Maraninchi, D Viens, P
Citation: C. Chabannon et al., Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-dosesof cyclophosphamide, INT J ONCOL, 15(3), 1999, pp. 511-518

Authors: Le Corroller, AG Moatti, JP Chabannon, C Faucher, C Fortanier, C Ladaique, P Blache, JL Novakovitch, G Maraninchi, D Blaise, D
Citation: Ag. Le Corroller et al., Optimization of peripheral blood stem cell collection by leukopheresis - Interaction between economic and clinical assessment of an innovation, INT J TE A, 15(1), 1999, pp. 161-172
Risultati: 1-9 |